WIN 2017 conference review
5 Jul 2017
WIN 2017 conference review
The challenge of approving add-on therapies for patients with metastatic cancer
Molecular medicine in lung cancer
Biomarker research in breast cancer
New biomarkers for response to immunotherapy
Combining immune-based therapies with TKIs in melanomas
Current and future immune approaches in precision medicine
Precision medicine enabled histology agnostic development of immunotherapeutics
Incorporating liquid biopsies into clinical trials
DNA damage response inhibition
Big data, scientific wellness and transforming healthcare
Bayesian adaptive trial designs for precision medicine